Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Schreiner MediPharm, OECHSLERhealth Introduce Cap-Lock for Vials | Contract Pharma

What are you searching for?

Sign in
Breaking News

Schreiner MediPharm, OECHSLERhealth Introduce Cap-Lock for Vials

Is designed to enhance vial security and support packaging digitalization.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Schreiner MediPharm and CDMO OECHSLERhealth have launched Cap‑Lock for Vials, a combined analog–digital first‑opening indication system designed to enhance vial security and support packaging digitalization.

The solution pairs Schreiner MediPharm’s Cap‑Lock Label—engineered to provide an irreversible first‑opening indication—with a plastic cap from OECHSLERhealth that mechanically interlocks with the vial’s flip‑off cap. When the vial is opened, the label is permanently destroyed, preventing undetected reclosure.

Cap‑Lock also integrates digital features, including an RFID chip for unit‑level tracking and automated detection of previously opened vials in clinical or hospital settings. Optional NFC functionality enables smartphone‑based authentication to support product and brand protection.

Compatible with standard vial sizes, the system is intended to help pharmaceutical manufacturers improve product integrity from filling to patient use, while advancing transparency and automation across the supply chain.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics